Sociedad Americana de Hirudoterapia

Hirudotherapy in Wound Healing

Nair HKR, Ahmad NW, Lee HL, Ahmad N, Othamn S, Mokhtar NSHM, Chong SSY (2020) · The International Journal of Lower Extremity Wounds · n=3

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidence
Sample size of this trial compared with other diabetic-foot-ulcer trialsNayak S 200842Nair HKR 20203Katkar R 20251
This trial (highlighted) by sample size alongside other indexed diabetic-foot-ulcer trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-center case series of hirudotherapy for chronic wound management (Hospital Kuala Lumpur and Institute for Medical Research, Malaysia)
Sample size (n)
3
Intervention
Sterile medicinal leeches (Hirudinaria manillensis) applied to chronic wounds and pain sites until detached spontaneously; full sterile-technique protocol with non-tooth plastic forceps and biohazard disposal
Comparator
No randomized comparator - descriptive case series outcomes
Primary endpoint
Pain reduction, wound healing progression, and patient-reported balance/comfort outcomes
Primary result
All 3 patients showed improvements in their condition, especially reduction in pain and improvement in sense of balance; all wounds healed well; authors conclude hirudotherapy is effective but note small sample size and need for more robust trials to establish significance
Follow-up duration
until wound resolution

Key Findings

  • Malaysian hospital-based case series documenting hirudotherapy protocols using Hirudinaria manillensis (Asian medicinal leech)
  • All three patients reported pain reduction and improvement in balance/comfort metrics
  • Detailed sterile-technique and biohazard-disposal protocol documented
  • Authors explicitly call for larger, more robust trials to confirm significance
  • Uses a different leech species (H. manillensis) than the European H. medicinalis - adds species coverage to the literature

Limitations

  • Very small case series (n=3) - hypothesis-generating only
  • No randomized control or sham comparison
  • Mixed wound etiologies in the case series limit attribution to specific pathology
  • Different leech species (Hirudinaria manillensis) not FDA-cleared in the US
  • Outcomes assessed by treating clinicians without standardized blinded scoring

Clinical Implications

Nair 2020 documents the Malaysian government-hospital approach to hirudotherapy for chronic wound healing using a non-European leech species (Hirudinaria manillensis). For US clinicians, the species difference limits direct applicability under the FDA K040187 clearance framework, which specifies whole-leech H. medicinalis. The case series provides useful operational documentation of sterile-technique and biohazard-disposal protocols but cannot establish efficacy at any meaningful evidence level. The trial supports calls for larger species-specific RCTs in chronic wound healing.

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.